Literature DB >> 25724113

Characteristics and prognosis of pulmonary infection in patients with neurologic disease and hypoproteinemia.

Feng Li1, Mei-zhen Yuan, Liang Wang, Xue-feng Wang, Guang-wei Liu.   

Abstract

OBJECTIVE: To examine the characteristics and the prognostic influence of pulmonary infections in neurologic disease patients with mild-to-severe hypoproteinemia.
METHODS: We used a retrospective survey method to analyze the characteristics and prognoses of 220 patients with hypoproteinemia complicated with pulmonary infection in the Internal Medicine-Neurology Intensive Care Unit at the First Affiliated Hospital of Chongqing Medical University from January 2010 to December 2013. The patients were divided into mild, moderate and severe hypoproteinemia groups according to their serum albumin levels. The analysis included patient age, sex, acute physiology and chronic health evaluation (APACHE II score), and characteristics of the pulmonary infection, nutritional support and prognosis, among others.
RESULTS: Differences in the general information of the 220 cases of hypoalbuminemia patients complicated with varying degrees of pulmonary infection (APACHE II score, age, disease distribution) were statistically significant. The pulmonary infection onset time and pathogen susceptibility in the patients with mild-to-severe hypoalbuminemia were not significantly different. Pulmonary infection onset was more frequently observed within the first 3-11 days following admission in all groups. The nutritional support method did not significantly influence serum albumin protein levels. However, the neurological intensive care unit stay length, total hospitalization cost and disease distribution were significantly different among the patient groups.
CONCLUSIONS: Patients with cerebrovascular disease, intracranial infections and epilepsy complicated with pulmonary infection represent the high-risk groups for hypoalbuminemia. The Acinetobacter baumannii complex represents the main group of pathogenic bacteria causing lung infections, and the high-risk period for lung infections is 3-11 days after the occurrence of hypoalbuminemia. Patients with severe hypoalbuminemia complicated with pulmonary infection have the worst prognoses.

Entities:  

Keywords:  hypoproteinemia; neurologic disease; nutritional support; prognosis; pulmonary infection

Mesh:

Year:  2015        PMID: 25724113     DOI: 10.1586/14787210.2015.1019471

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  5 in total

1.  Clinical Application and Evaluation of Metagenomic Next-Generation Sequencing in Pulmonary Infection with Pleural Effusion.

Authors:  Huifen Xu; Xiaoman Hu; Wenyu Wang; Hong Chen; Fangfei Yu; Xiaofei Zhang; Weili Zheng; Kaiyu Han
Journal:  Infect Drug Resist       Date:  2022-06-01       Impact factor: 4.177

2.  Pressure ulcer healing promoted by adequate protein intake in rats.

Authors:  Zhanfen Qin; Yao Wang; Wei Zhao; Yanan Zhang; Yiqing Tian; Sujuan Sun; Xian Li
Journal:  Exp Ther Med       Date:  2018-03-08       Impact factor: 2.447

3.  Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.

Authors:  Mutsuo Yamaya; Osamu Usami; Shoichi Nakayama; Naoki Tode; Aya Yamada; Shunsuke Ito; Fumiya Omata; Haruki Momma; Masakatsu Funakubo; Masakazu Ichinose
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-04-22

4.  Analysis of the Need for Postoperative Drainage Application for Hip Arthroplasty: A Systematic Review and Meta-Analysis.

Authors:  Min Yang; Chunwen Yan; Nasha Niu; Yingzi Lu; Wei Yue; Li Pan
Journal:  Comput Math Methods Med       Date:  2022-02-24       Impact factor: 2.238

5.  Comparison of electrolyte and glucose levels measured by a blood gas analyzer and an automated biochemistry analyzer among hospitalized patients.

Authors:  Huo-Chun Yi; Wen-Sheng Shi; Yin-Hui Zhang; Xiao-Zhen Zhu; Yang Yu; Xin-Xin Wang; Zhang Dai; Yong Lin
Journal:  J Clin Lab Anal       Date:  2020-03-09       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.